These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

82 related items for PubMed ID: 1694159

  • 1. [Vitronectin: mediator of cell adhesion in proliferative vitreoretinopathy?].
    Weller M, Wiedemann P, Bresgen M, Heimann K.
    Fortschr Ophthalmol; 1990; 87(2):221-5. PubMed ID: 1694159
    [Abstract] [Full Text] [Related]

  • 2. The role of fibronectin, laminin, vitronectin and their receptors on cellular adhesion in proliferative vitreoretinopathy.
    Casaroli Marano RP, Vilaró S.
    Invest Ophthalmol Vis Sci; 1994 May; 35(6):2791-803. PubMed ID: 7514582
    [Abstract] [Full Text] [Related]

  • 3. Vitronectin and proliferative intraocular disorders. I. A colocalisation study of the serum spreading factor, vitronectin, and fibronectin in traction membranes from patients with proliferative vitreoretinopathy.
    Weller M, Wiedemann P, Bresgen M, Heimann K.
    Int Ophthalmol; 1991 Mar; 15(2):93-101. PubMed ID: 1708748
    [Abstract] [Full Text] [Related]

  • 4. [Proliferative vitreoretinopathy: new discoveries in pathophysiology and therapy].
    Wiedemann P, Weller M, Heimann K.
    Klin Monbl Augenheilkd; 1990 Nov; 197(5):355-61. PubMed ID: 2290290
    [Abstract] [Full Text] [Related]

  • 5. Pathogenesis of proliferative vitreoretinopathy. Modulation of retinal pigment epithelial cell functions by vitreous and macrophages.
    Kirchhof B, Sorgente N.
    Dev Ophthalmol; 1989 Nov; 16():1-53. PubMed ID: 2676632
    [Abstract] [Full Text] [Related]

  • 6. [Role of macrophages and fibronectin in vitreoretinal proliferation].
    Weller M, Heimann K, Wiedemann P.
    J Fr Ophtalmol; 1988 Nov; 11(3):243-7. PubMed ID: 3047202
    [Abstract] [Full Text] [Related]

  • 7. [Proliferative vitreoretinopathy. On the significance of protein transfer through the blood-retina barrier].
    Grisanti S, Wiedemann P, Heimann K.
    Ophthalmologe; 1993 Oct; 90(5):468-71. PubMed ID: 8219633
    [Abstract] [Full Text] [Related]

  • 8. A prospective study of matrix metalloproteinases in proliferative vitreoretinopathy.
    Kon CH, Occleston NL, Charteris D, Daniels J, Aylward GW, Khaw PT.
    Invest Ophthalmol Vis Sci; 1998 Jul; 39(8):1524-9. PubMed ID: 9660504
    [Abstract] [Full Text] [Related]

  • 9. Immunoreactive ET-1 in the vitreous humor and epiretinal membranes of patients with proliferative vitreoretinopathy.
    Roldán-Pallarés M, Rollín R, Mediero A, Martínez-Montero JC, Fernández-Cruz A, Bravo-Llata C, Fernández-Durango R.
    Mol Vis; 2005 Jul 07; 11():461-71. PubMed ID: 16030497
    [Abstract] [Full Text] [Related]

  • 10. [Vitronectin and fibronectin receptors in proliferative retinal diseases].
    Esser P, Weller M, Heimann K, Wiedemann P.
    Fortschr Ophthalmol; 1990 Jul 07; 87(4):344-7. PubMed ID: 1698696
    [Abstract] [Full Text] [Related]

  • 11. [Detection of coagulation factor XIII in the vitreous body and periretinal membranes in proliferative retinal diseases].
    Bresgen M, Weller M, Heimann K, Wiedemann P.
    Fortschr Ophthalmol; 1990 Jul 07; 87(3):279-82. PubMed ID: 2198204
    [Abstract] [Full Text] [Related]

  • 12. Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy.
    Abu El-Asrar AM, Struyf S, Kangave D, Geboes K, Van Damme J.
    Eur Cytokine Netw; 2006 Sep 07; 17(3):155-65. PubMed ID: 17194635
    [Abstract] [Full Text] [Related]

  • 13. Upregulation of RAGE and its ligands in proliferative retinal disease.
    Pachydaki SI, Tari SR, Lee SE, Ma W, Tseng JJ, Sosunov AA, Cataldergirmen G, Scarmeas N, Caspersen C, Chang S, Schiff WM, Schmidt AM, Barile GR.
    Exp Eye Res; 2006 May 07; 82(5):807-15. PubMed ID: 16364297
    [Abstract] [Full Text] [Related]

  • 14. [Immunohistochemical findings in proliferative retinal diseases--on the significance of fibronectin, macrophages and transferrin].
    Weller M, Heimann K, Wiedemann P.
    Fortschr Ophthalmol; 1989 May 07; 86(2):121-3. PubMed ID: 2661370
    [Abstract] [Full Text] [Related]

  • 15. Ribozyme to proliferating cell nuclear antigen to treat proliferative vitreoretinopathy.
    Mandava N, Blackburn P, Paul DB, Wilson MW, Read SB, Alspaugh E, Tritz R, Barber JR, Robbins JM, Kruse CA.
    Invest Ophthalmol Vis Sci; 2002 Oct 07; 43(10):3338-48. PubMed ID: 12356843
    [Abstract] [Full Text] [Related]

  • 16. Tenascin and decorin in epiretinal membranes of proliferative vitreoretinopathy and proliferative diabetic retinopathy.
    Hagedorn M, Esser P, Wiedemann P, Heimann K.
    Ger J Ophthalmol; 1993 Feb 07; 2(1):28-31. PubMed ID: 7679595
    [Abstract] [Full Text] [Related]

  • 17. The effect of extracellular matrix molecules on the in vitro behavior of bovine endothelial cells.
    Underwood PA, Bennett FA.
    Exp Cell Res; 1993 Apr 07; 205(2):311-9. PubMed ID: 7683271
    [Abstract] [Full Text] [Related]

  • 18. [Vitreoretinal proliferation. I. Clinicopathological aspects].
    Baudouin C, Gastaud P.
    J Fr Ophtalmol; 1994 Apr 07; 17(12):789-99. PubMed ID: 7722242
    [Abstract] [Full Text] [Related]

  • 19. A monoclonal antibody inhibits adhesion to fibronectin and vitronectin of a colon carcinoma cell line and recognizes the integrins alpha v beta 3, alpha v beta 5, and alpha v beta 6.
    Lehmann M, Rabenandrasana C, Tamura R, Lissitzky JC, Quaranta V, Pichon J, Marvaldi J.
    Cancer Res; 1994 Apr 15; 54(8):2102-7. PubMed ID: 7513610
    [Abstract] [Full Text] [Related]

  • 20. [Quantitative determination of 5 vitreal proteins in the normal vitreous body and proliferative retinal diseases].
    Clausen R, Weller M, Hilgers RD, Heimann K, Wiedemann P.
    Fortschr Ophthalmol; 1990 Apr 15; 87(3):283-6. PubMed ID: 2376377
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.